The importance of serine metabolism in cancer

Journal of Cell Biology

Volumn 214, Issue 3, 2016, Pages 249-257

  Mattaini, Katherine R ^a,d   Sullivan, Mark R ^a   Vander Heiden, Matthew G ^a,b,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE; NUCLEOTIDE; PHOSPHOGLYCERATE DEHYDROGENASE;

AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; AMINO ACID TRANSPORT; CANCER CELL; FOLATE METABOLISM; GLYCOLYSIS; HOMEOSTASIS; HUMAN; NEOPLASM; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CHEMISTRY; METABOLISM;

ANIMALS; BIOSYNTHETIC PATHWAYS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NUCLEOTIDES; PHOSPHOGLYCERATE DEHYDROGENASE; SERINE;

EID: 84980041497     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201604085     Document Type: Review

References (82)

1. Achouri, Y., M.H. Rider, E.V. Schaftingen, and M. Robbi. 1997. Cloning, sequencing and expression of rat liver 3-phosphoglycerate dehydrogenase. Biochem. J. 323:365-370. http://dx.doi.org/10.1042/bj3230365.
2. Acuna-Hidalgo, R., D. Schanze, A. Kariminejad, A. Nordgren, M.H. Kariminejad, P. Conner, G. Grigelioniene, D. Nilsson, M. Nordenskjöld, A. Wedell, et al. 2014. Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway. Am. J. Hum. Genet. 95:285-293. http://dx.doi.org/10.1016/j.ajhg.2014.07.012.
3. Adams, C.M. 2007. Role of the transcription factor ATF4 in the anabolic actions of insulin and the anti-anabolic actions of glucocorticoids. J. Biol. Chem. 282:16744-16753. http://dx.doi.org/10.1074/jbc.M610510200.
4. Anastasiou, D., Y. Yu, W.J. Israelsen, J.K. Jiang, M.B. Boxer, B.S. Hong, W. Tempel, S. Dimov, M. Shen, A. Jha, et al. 2012. Pyruvate kinase M2. activators promote tetramer formation and suppress tumorigenesis. Nat. Chem. Biol. 8:839-847. http://dx.doi.org/10.1038/nchembio.1060.
5. Bao, X.R., S.E. Ong, O. Goldberger, J. Peng, R. Sharma, D.A. Thompson, S.B. Vafai, A.G. Cox, E. Marutani, F. Ichinose, et al. 2016. Mitochondrial dysfunction remodels one-carbon metabolism in human cells. eLife. 5:5. http://dx.doi.org/10.7554/eLife.10575.
6. Ben-Sahra, I., G. Hoxhaj, S.J. Ricoult, J.M. Asara, and B.D. Manning. 2016. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science. 351:728-733. http://dx.doi.org/10.1126/science.aad0489.
7. Beroukhim, R., C.H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, J. Donovan, J. Barretina, J.S. Boehm, J. Dobson, M. Urashima, et al. 2010. The landscape of somatic copy-number alteration across human cancers. Nature. 463:899-905. http://dx.doi.org/10.1038/nature08822.
8. Cairns, R.A., I.S. Harris, and T.W. Mak. 2011. Regulation of cancer cell metabolism. Nat. Rev. Cancer. 11:85-95. http://dx.doi.org/10.1038/nrc2981.
9. Chaneton, B., P. Hillmann, L. Zheng, A.C. Martin, O.D. Maddocks, A. Chokkathukalam, J.E. Coyle, A. Jankevics, F.P. Holding, K.H. Vousden, et al. 2012. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature. 491:458-462. http://dx.doi.org/10.1038/nature11540.
10. Chen, J., F. Chung, G. Yang, M. Pu, H. Gao, W. Jiang, H. Yin, V. Capka, S. Kasibhatla, B. Laffitte, et al. 2013. Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth. Oncotarget. 4:2502-2511. http://dx.doi.org/10.18632/oncotarget.1540.
11. Cheung, G.P., J.P. Cotropia, and H.J. Sallach. 1969. The effects of dietary protein on the hepatic enzymes of serine metabolism in the rabbit. Arch. Biochem. Biophys. 129:672-682. http://dx.doi.org/10.1016/0003-9861(69)90227-6.
12. Christofk, H.R., M.G. Vander Heiden, M.H. Harris, A. Ramanathan, R.E. Gerszten, R. Wei, M.D. Fleming, S.L. Schreiber, and L.C. Cantley. 2008a. The M2. splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 452:230-233. http://dx.doi.org/10.1038/nature06734.
13. Christofk, H.R., M.G. Vander Heiden, N. Wu, J.M. Asara, and L.C. Cantley. 2008b. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature. 452:181-186. http://dx.doi.org/10.1038/nature06667.
14. Dang, L., D.W. White, S. Gross, B.D. Bennett, M.A. Bittinger, E.M. Driggers, V.R. Fantin, H.G. Jang, S. Jin, M.C. Keenan, et al. 2009. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 462:739-744. http://dx.doi.org/10.1038/nature08617.
15. Davidson, S.M., T. Papagiannakopoulos, B.A. Olenchock, J.E. Heyman, M.A. Keibler, A. Luengo, M.R. Bauer, A.K. Jha, J.P. O'Brien, K.A. Pierce, et al. 2016. Environment impacts the metabolic dependencies of Rasdriven non-small cell lung cancer. Cell Metab. 23:517-528. http://dx.doi.org/10.1016/j.cmet.2016.01.007.
16. Davis, J.L., H.J. Fallon, and H.P. Morris. 1970. Two enzymes of serine metabolism in rat liver and hepatomas. Cancer Res. 30:2917-2920.
17. DeBerardinis, R.J., and T. Cheng. 2010. Q's next: The diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 29:313-324. http://dx.doi.org/10.1038/onc.2009.358.
18. DeNicola, G.M., P.H. Chen, E. Mullarky, J.A. Sudderth, Z. Hu, D. Wu, H. Tang, Y. Xie, J.M. Asara, K.E. Huffman, et al. 2015. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat. Genet. 47:1475-1481. http://dx.doi.org/10.1038/ng.3421.
19. Dey, S., Z. Hu, X.L. Xu, J.C. Sacchettini, and G.A. Grant. 2005. D-3-phosphoglycerate dehydrogenase from Mycobacterium tuberculosis is a link between the Escherichia coli and mammalian enzymes. J. Biol. Chem. 280:14884-14891. http://dx.doi.org/10.1074/jbc.M414488200.
20. Ding, J., T. Li, X. Wang, E. Zhao, J.H. Choi, L. Yang, Y. Zha, Z. Dong, S. Huang, J.M. Asara, et al. 2013. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab. 18:896-907. http://dx.doi.org/10.1016/j.cmet.2013.11.004.
21. Ducker, G.S., L. Chen, R.J. Morscher, J.M. Ghergurovich, M. Esposito, X. Teng, Y. Kang, and J.D. Rabinowitz. 2016. Reversal of cytosolic one-carbon flux compensates for loss of the mitochondrial folate pathway. Cell Metab. 23:1140-1153. http://dx.doi.org/10.1016/j.cmet.2016.04.016.
22. Eichler, H.G., R. Hubbard, and K. Snell. 1981. The role of serine hydroxymethyltransferase in cell proliferation: DNA synthesis from serine following mitogenic stimulation of lymphocytes. Biosci. Rep. 1:101-106. http://dx.doi.org/10.1007/BF01117006.
23. Eigenbrodt, E., S. Leib, W. Kramer, R.R. Friis, and W. Schoner. 1983. Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors. Biomed. Biochim. Acta. 42:S278-S282.
24. El-Hattab, A.W. 2016. Serine biosynthesis and transport defects. Mol. Genet. Metab. 118:153-159. http://dx.doi.org/10.1016/j.ymgme.2016.04.010.
25. Fan, J., J. Ye, J.J. Kamphorst, T. Shlomi, C.B. Thompson, and J.D. Rabinowitz. 2014. Quantitative flux analysis reveals folate-dependent NAD PH production. Nature. 510:298-302. http://dx.doi.org/10.1038/nature13236.
26. Fan, J., X. Teng, L. Liu, K.R. Mattaini, R.E. Looper, M.G. Vander Heiden, and J.D. Rabinowitz. 2015. Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate. ACS Chem. Biol. 10:510-516. http://dx.doi.org/10.1021/cb500683c
27. Gui, D.Y., C.A. Lewis, and M.G. Vander Heiden. 2013. Allosteric regulation of PKM2 allows cellular adaptation to different physiological states. Sci. Signal. 6:pe7. http://dx.doi.org/10.1126/scisignal.2003925.
28. Hensley, C.T., B. Faubert, Q. Yuan, N. Lev-Cohain, E. Jin, J. Kim, L. Jiang, B. Ko, R. Skelton, L. Loudat, et al. 2016. Metabolic heterogeneity in human lung tumors. Cell. 164:681-694. http://dx.doi.org/10.1016/j.cell.2015.12.034.
29. Herbig, K., E.P. Chiang, L.R. Lee, J. Hills, B. Shane, and P.J. Stover. 2002. Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J. Biol. Chem. 277:38381-38389. http://dx.doi.org/10.1074/jbc.M205000200.
30. Hitosugi, T., S. Kang, M.G. Vander Heiden, T.W. Chung, S. Elf, K. Lythgoe, S. Dong, S. Lonial, X. Wang, G.Z. Chen, et al. 2009. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci. Signal. 2:ra73. http://dx.doi.org/10.1126/scisignal.2000431.
31. Hosios, A.M., V.C. Hecht, L.V. Danai, M.O. Johnson, J.C. Rathmell, M.L. Steinhauser, S.R. Manalis, and M.G. Vander Heiden. 2016. Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev. Cell. 36:540-549. http://dx.doi.org/10.1016/j.devcel.2016.02.012.
32. Hung, Y.P., J.G. Albeck, M. Tantama, and G. Yellen. 2011. Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor. Cell Metab. 14:545-554. http://dx.doi.org/10.1016/j.cmet.2011.08.012.
33. Ibsen, K.H., and S.W. Marles. 1976. Inhibition of chicken pyruvate kinases by amino acids. Biochemistry. 15:1073-1079. http://dx.doi.org/10.1021/bi00650a018.
34. Ichihara, A., and D.M. Greenberg. 1955. Pathway of serine formation from carbohydrate in rat liver. Proc. Natl. Acad. Sci. USA. 41:605-609. http://dx.doi.org/10.1073/pnas.41.9.605.
35. Israelsen, W.J., and M.G. Vander Heiden. 2015. Pyruvate kinase: Function, regulation and role in cancer. Semin. Cell Dev. Biol. 43:43-51. http://dx.doi.org/10.1016/j.semcdb.2015.08.004.
36. Israelsen, W.J., T.L. Dayton, S.M. Davidson, B.P. Fiske, A.M. Hosios, G. Bellinger, J. Li, Y. Yu, M. Sasaki, J.W. Horner, et al. 2013. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell. 155:397-409. http://dx.doi.org/10.1016/j.cell.2013.09.025.
37. Jain, M., R. Nilsson, S. Sharma, N. Madhusudhan, T. Kitami, A.L. Souza, R. Kafri, M.W. Kirschner, C.B. Clish, and V.K. Mootha. 2012. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 336:1040-1044. http://dx.doi.org/10.1126/science.1218595.
38. Jing, Z., W. Heng, D. Aiping, Q. Yafei, and Z. Shulan. 2013. Expression and clinical significance of phosphoglycerate dehydrogenase and squamous cell carcinoma antigen in cervical cancer. Int. J. Gynecol. Cancer. 23:1465-1469. http://dx.doi.org/10.1097/IGC.0b013e3182a0c068.
39. Kim, D., B.P. Fiske, K. Birsoy, E. Freinkman, K. Kami, R.L. Possemato, Y. Chudnovsky, M.E. Pacold, W.W. Chen, J.R. Cantor, et al. 2015. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature. 520:363-367. http://dx.doi.org/10.1038/nature14363.
40. Krall, A.S., S. Xu, T.G. Graeber, D. Braas, and H.R. Christofk. 2016. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nat. Commun. 7:11457. http://dx.doi.org/10.1038/ncomms11457.
41. Kung, C., J. Hixon, S. Choe, K. Marks, S. Gross, E. Murphy, B. DeLaBarre, G. Cianchetta, S. Sethumadhavan, X. Wang, et al. 2012. Small molecule activation of PKM2 in cancer cells induces serine auxotrophy. Chem. Biol. 19:1187-1198. http://dx.doi.org/10.1016/j.chembiol.2012.07.021.
42. Labuschagne, C.F., N.J. van den Broek, G.M. Mackay, K.H. Vousden, and O.D. Maddocks. 2014. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Reports. 7:1248-1258. http://dx.doi.org/10.1016/j.celrep.2014.04.045.
43. Lehninger, A.L., D.L. Nelson, and M.M. Cox. 2013. Lehninger principles of biochemistry. W.H. Freeman, New York. 1198 pp.
44. Lewis, C.A., S.J. Parker, B.P. Fiske, D. McCloskey, D.Y. Gui, C.R. Green, N.I. Vokes, A.M. Feist, M.G. Vander Heiden, and C.M. Metallo. 2014. Tracing compartmentalized NAD PH metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell. 55:253-263. http://dx.doi.org/10.1016/j.molcel.2014.05.008.
45. Liu, J., S. Guo, Q. Li, L. Yang, Z. Xia, L. Zhang, Z. Huang, and N. Zhang. 2013. Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1. J. Neurooncol. 111:245-255. http://dx.doi.org/10.1007/s11060-012-1018-x
46. Locasale, J.W. 2013. Serine, glycine and one-carbon units: Cancer metabolism in full circle. Nat. Rev. Cancer. 13:572-583. http://dx.doi.org/10.1038/nrc3557.
47. Locasale, J.W., A.R. Grassian, T. Melman, C.A. Lyssiotis, K.R. Mattaini, A.J. Bass, G. Heffron, C.M. Metallo, T. Muranen, H. Sharfi, et al. 2011. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43:869-874. http://dx.doi.org/10.1038/ng.890.
48. Lunt, S.Y., and M.G. Vander Heiden. 2011. Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27:441-464. http://dx.doi.org/10.1146/annurev-cellbio-092910-154237.
49. Lunt, S.Y., V. Muralidhar, A.M. Hosios, W.J. Israelsen, D.Y. Gui, L. Newhouse, M. Ogrodzinski, V. Hecht, K. Xu, P.N. Acevedo, et al. 2015. Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol. Cell. 57:95-107. http://dx.doi.org/10.1016/j.molcel.2014.10.027.
50. Maddocks, O.D., C.R. Berkers, S.M. Mason, L. Zheng, K. Blyth, E. Gottlieb, and K.H. Vousden. 2013. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature. 493:542-546. http://dx.doi.org/10.1038/nature11743.
51. Maddocks, O.D., C.F. Labuschagne, P.D. Adams, and K.H. Vousden. 2016. Serine metabolism supports the methionine cycle and DNA/RNA methylation through de novo ATP synthesis in cancer cells. Mol. Cell. 61:210-221. http://dx.doi.org/10.1016/j.molcel.2015.12.014.
52. Mattaini, K.R., E.J. Brignole, M. Kini, S.M. Davidson, B.P. Fiske, C.L. Drennan, and M.G. Vander Heiden. 2015. An epitope tag alters phosphoglycerate dehydrogenase structure and impairs ability to support cell proliferation. Cancer Metab. 3:5. http://dx.doi.org/10.1186/s40170-015-0131-7.
53. Mayers, J.R., and M.G. Vander Heiden. 2015. Famine versus feast: Understanding the metabolism of tumors in vivo. Trends Biochem. Sci. 40:130-140. http://dx.doi.org/10.1016/j.tibs.2015.01.004.
54. Mullarky, E., K.R. Mattaini, M.G. Vander Heiden, L.C. Cantley, and J.W. Locasale. 2011. PHG DH amplification and altered glucose metabolism in human melanoma. Pigment Cell Melanoma Res. 24:1112-1115. http://dx.doi.org/10.1111/j.1755-148X.2011.00919.x
55. Mullarky, E., N.C. Lucki, R. Beheshti Zavareh, J.L. Anglin, A.P. Gomes, B.N. Nicolay, J.C. Wong, S. Christen, H. Takahashi, P.K. Singh, et al. 2016. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proc. Natl. Acad. Sci. USA. 113:1778-1783. http://dx.doi.org/10.1073/pnas.1521548113.
56. Muthuswamy, S.K., D. Li, S. Lelievre, M.J. Bissell, and J.S. Brugge. 2001. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 3:785-792. http://dx.doi.org/10.1038/ncb0901-785.
57. Nilsson, L.M., T.Z. Forshell, S. Rimpi, C. Kreutzer, W. Pretsch, G.W. Bornkamm, and J.A. Nilsson. 2012. Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesis. PLoS Genet. 8:e1002573. http://dx.doi.org/10.1371/journal.pgen.1002573.
58. Nilsson, R., M. Jain, N. Madhusudhan, N.G. Sheppard, L. Strittmatter, C. Kampf, J. Huang, A. Asplund, and V.K. Mootha. 2014. Metabolic enzyme expression highlights a key role for MTH FD2 and the mitochondrial folate pathway in cancer. Nat. Commun. 5:3128. http://dx.doi.org/10.1038/ncomms4128.
59. Pacold, M.E., K.R. Brimacombe, S.H. Chan, J.M. Rohde, C.A. Lewis, L.J.Y.M. Swier, R. Possemato, W.W. Chen, L.B. Sullivan, B.P. Fiske, et al. 2016. A PHG DH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat. Chem. Biol. 12:452-458. http://dx.doi.org/10.1038/nchembio.2070.
60. Pikman, Y., A. Puissant, G. Alexe, A. Furman, L.M. Chen, S.M. Frumm, L. Ross, N. Fenouille, C.F. Bassil, C.A. Lewis, et al. 2016. Targeting MTH FD2 in acute myeloid leukemia. J. Exp. Med. 213:1285-1306. http://dx.doi.org/10.1084/jem.20151574.
61. Piskounova, E., M. Agathocleous, M.M. Murphy, Z. Hu, S.E. Huddlestun, Z. Zhao, A.M. Leitch, T.M. Johnson, R.J. DeBerardinis, and S.J. Morrison. 2015. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 527:186-191. http://dx.doi.org/10.1038/nature15726.
62. Pizer, L.I. 1963. The pathway and control of serine biosynthesis in Escherichia coli. J. Biol. Chem. 238:3934-3944.
63. Pollari, S., S.M. Käkönen, H. Edgren, M. Wolf, P. Kohonen, H. Sara, T. Guise, M. Nees, and O. Kallioniemi. 2011. Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res. Treat. 125:421-430. http://dx.doi.org/10.1007/s10549-010-0848-5.
64. Possemato, R., K.M. Marks, Y.D. Shaul, M.E. Pacold, D. Kim, K. Birsoy, S. Sethumadhavan, H.K. Woo, H.G. Jang, A.K. Jha, et al. 2011. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 476:346-350. http://dx.doi.org/10.1038/nature10350.
65. Sallach, H.J. 1955. Evidence for a specific alanine-hydroxypyruvic transaminase. In Amino Acid Metabolism. W.D. McElroy, and B. Glass, editors. Johns Hopkins, Baltimore. 782-796.
66. Schafer, Z.T., A.R. Grassian, L. Song, Z. Jiang, Z. Gerhart-Hines, H.Y. Irie, S. Gao, P. Puigserver, and J.S. Brugge. 2009. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature. 461:109-113. http://dx.doi.org/10.1038/nature08268.
67. Snell, K. 1984. Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv. Enzyme Regul. 22:325-400. http://dx.doi.org/10.1016/0065-2571(84)90021-9.
68. Snell, K., and G. Weber. 1986. Enzymic imbalance in serine metabolism in rat hepatomas. Biochem. J. 233:617-620. http://dx.doi.org/10.1042/bj2330617.
69. Snell, K., Y. Natsumeda, and G. Weber. 1987. The modulation of serine metabolism in hepatoma 3924A during different phases of cellular proliferation in culture. Biochem. J. 245:609-612. http://dx.doi.org/10.1042/bj2450609.
70. Suda, M. 1967. A view of the comparison of the regulation of enzymes in mammalian and microbial systems. Adv. Enzyme Regul. 5:181-209. http://dx.doi.org/10.1016/0065-2571(67)90016-7.
71. Sullivan, L.B., D.Y. Gui, A.M. Hosios, L.N. Bush, E. Freinkman, and M.G. Vander Heiden. 2015. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell. 162:552-563. http://dx.doi.org/10.1016/j.cell.2015.07.017.
72. Tibbetts, A.S., and D.R. Appling. 2010. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 30:57-81. http://dx.doi.org/10.1146/annurev.nutr.012809.104810.
73. Umbarger, H.E., and M.A. Umbarger. 1962. The biosynthetic pathway of serine in Salmonella typhimurium. Biochim. Biophys. Acta. 62:193-195. http://dx.doi.org/10.1016/0006-3002(62)90515-2.
74. van der Crabben, S.N., N.M. Verhoeven-Duif, E.H. Brilstra, L. Van Maldergem, T. Coskun, E. Rubio-Gozalbo, R. Berger, and T.J. de Koning. 2013. An update on serine deficiency disorders. J. Inherit. Metab. Dis. 36:613-619. http://dx.doi.org/10.1007/s10545-013-9592-4.
75. Vander Heiden, M.G. 2011. Targeting cancer metabolism: A therapeutic window opens. Nat. Rev. Drug Discov. 10:671-684. http://dx.doi.org/10.1038/nrd3504.
76. Ward, P.S., J. Patel, D.R. Wise, O. Abdel-Wahab, B.D. Bennett, H.A. Coller, J.R. Cross, V.R. Fantin, C.V. Hedvat, A.E. Perl, et al. 2010. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting a-ketoglutarate to 2-hydroxyglutarate. Cancer Cell. 17:225-234. http://dx.doi.org/10.1016/j.ccr.2010.01.020.
77. White, E. 2013. Exploiting the bad eating habits of Ras-driven cancers. Genes Dev. 27:2065-2071. http://dx.doi.org/10.1101/gad.228122.113.
78. Ye, J., A. Mancuso, X. Tong, P.S. Ward, J. Fan, J.D. Rabinowitz, and C.B. Thompson. 2012. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc. Natl. Acad. Sci. USA. 109:6904-6909. http://dx.doi.org/10.1073/pnas.1204176109.
79. Ye, J., J. Fan, S. Venneti, Y.W. Wan, B.R. Pawel, J. Zhang, L.W. Finley, C. Lu, T. Lindsten, J.R. Cross, et al. 2014. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov. 4:1406-1417. http://dx.doi.org/10.1158/2159-8290.CD-14-0250.
80. Yoshida, K., S. Furuya, S. Osuka, J. Mitoma, Y. Shinoda, M. Watanabe, N. Azuma, H. Tanaka, T. Hashikawa, S. Itohara, and Y. Hirabayashi. 2004. Targeted disruption of the mouse 3-phosphoglycerate dehydrogenase gene causes severe neurodevelopmental defects and results in embryonic lethality. J. Biol. Chem. 279:3573-3577. http://dx.doi.org/10.1074/jbc.C300507200.
81. Zhao, G., and M.E. Winkler. 1996. A novel alpha-ketoglutarate reductase activity of the serA-encoded 3-phosphoglycerate dehydrogenase of Escherichia coli K-12 and its possible implications for human 2-hydroxyglutaric aciduria. J. Bacteriol. 178:232-239.
82. Zogg, C.K. 2014. Phosphoglycerate dehydrogenase: Potential therapeutic target and putative metabolic oncogene. J. Oncol. 2014:524101. http://dx.doi.org/10.1155/2014/524101.